Insider Trading & Ownership - Shukla Sanjay

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Shukla Sanjay
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-31
Purchase
2024-06-03
08:34 am
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
20,000$1.807$36,140136,548
(Direct)
View
2023-12-11
Purchase
2023-12-12
6:50 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
15,000$1.1764$17,646106,173
(Direct)
View
2023-11-10
Purchase
2023-11-13
4:11 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
15,000$1.1136$16,70391,173
(Direct)
View
2023-07-28
Purchase
2023-08-01
4:07 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
15,000$2.0149$30,22476,173
(Direct)
View
2022-11-21
Purchase
2022-11-21
9:04 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
10,000$2.1405$21,40550,798
(Direct)
View
2022-07-01
Purchase
2022-07-06
5:02 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
15,000$2.8776$43,16440,798
(Direct)
View
2022-01-07
Purchase
2022-01-10
8:03 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
5,000$6.7613$33,80725,798
(Direct)
View
2021-11-15
Purchase
2021-11-15
6:56 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
2,500$8.575$21,43820,798
(Direct)
View
2021-05-18
Purchase
2021-05-20
08:52 am
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
10,000$4.01$40,10018,298
(Direct)
View
2021-02-09
Sale
2021-02-09
9:12 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
778$7.66$5,9598,298
(Direct)
View
2020-06-19
Purchase
2020-06-23
4:23 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
6,000$4.27$25,6207,291
(Direct)
View
2020-02-07
Sale
2020-02-07
7:37 pm
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
745$4.03$3,00242,404
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-05
Exercise
2024-02-06
8:20 pm
N/A
N/A
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
10,375$0137,298
(Direct)
View
2024-01-05
Option Award
2024-01-09
7:35 pm
N/A
2034-01-05
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
600,000$0600,000
(Direct)
View
2023-02-16
Option Award
2023-02-21
5:08 pm
N/A
2033-02-16
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
336,096$0336,096
(Direct)
View
2023-02-03
Exercise
2023-02-06
6:57 pm
N/A
N/A
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
10,375$092,298
(Direct)
View
2022-05-24
Option Award
2022-05-26
4:30 pm
N/A
2032-05-24
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
516,280$0516,280
(Direct)
View
2022-02-03
Option Award
2022-02-07
4:52 pm
N/A
2032-02-03
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
124,500$0124,500
(Direct)
View
2021-05-21
Option Award
2021-05-25
9:03 pm
N/A
2025-05-21
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
207,000$0207,000
(Direct)
View
2021-02-04
Option Award(A)
2021-03-09
4:29 pm
N/A
2031-02-04
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
112,469$0112,469
(Direct)
View
2020-05-26
Option Award(A)
2021-03-09
4:23 pm
N/A
2030-05-26
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
73,142$073,142
(Direct)
View
2021-02-06
Exercise
2021-02-09
9:12 pm
N/A
N/A
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
1,785$08,298
(Direct)
View
2021-02-04
Option Award
2021-02-08
8:18 pm
N/A
2031-02-04
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
120,000$0120,000
(Direct)
View
2020-05-26
Option Award
2020-05-28
8:17 pm
N/A
2030-05-26
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
80,000$00
(Direct)
View
2020-02-06
Exercise
2020-02-07
7:37 pm
N/A
N/A
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
1,786$042,404
(Direct)
View
2020-02-05
Option Award
2020-02-07
7:37 pm
N/A
2030-02-05
aTYR PHARMA INCLIFEShukla Sanjay
President and CEO
39,327$042,404
(Direct)
View
(A) Indicate amendment filing.